Nektar’s Skin Drug Buzz: Should You Jump In?

Nektar’s stock just shot up after-hours because they’re about to drop big news on a new eczema treatment. If you’ve ever dealt with itchy skin or know someone who has, this could be a game-changer. The hype is real—message boards are blowing up, and some folks are betting the stock will keep climbing. But with the company’s recent losses, some investors are playing it safe and cashing out early. Would you ride the wave or lock in your gains? #stocks #biotech #investing #Business #Market